ATP6AP2 and breast carcinoma: Among these subunits, we demonstrated that ATP6AP2 was downregulated in therapy-induced senescent breast cancer cells, causing intracellular acidification (reduction in pHi) and lysosomal alkalinization (elevation in pHL).